Protagonist Therapeutics Ownership | Who Owns Protagonist Therapeutics?
Protagonist Therapeutics Ownership Summary
Protagonist Therapeutics is owned by 99.41% institutional investors, 1.18% insiders. Farallon capital management is the largest institutional shareholder, holding 9.53% of PTGX shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.30% of its assets in Protagonist Therapeutics shares.
PTGX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Protagonist Therapeutics | 99.41% | 1.18% | -0.59% |
Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Farallon capital management | 5.84M | 9.53% | $202.38M |
Blackrock | 5.76M | 9.39% | $199.52M |
Rtw investments, lp | 5.29M | 8.62% | $183.17M |
Bvf inc/il | 3.32M | 5.41% | $115.01M |
Vanguard group | 3.24M | 5.29% | $112.39M |
Johnson & johnson | 2.45M | 4.00% | $84.86M |
State street | 2.08M | 3.40% | $72.15M |
Jefferies financial group | 2.04M | 3.33% | $70.71M |
Adage capital partners gp | 2.00M | 3.26% | $69.35M |
Adar1 capital management | 1.60M | 2.62% | $55.58M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Johnson & johnson | 2.45M | 21.18% | $84.86M |
Adar1 capital management | 1.60M | 10.49% | $55.58M |
Checkpoint capital | 355.00K | 7.42% | $12.30M |
Bvf inc/il | 3.32M | 3.22% | $115.01M |
Rtw investments, lp | 5.29M | 2.84% | $183.17M |
Kynam capital management, lp | 800.00K | 2.14% | $27.72M |
683 capital management | 604.45K | 1.58% | $20.94M |
Birchview capital, lp | 48.00K | 1.54% | $1.66M |
Eversept partners, lp | 505.84K | 1.20% | $17.53M |
Mangrove partners | 439.31K | 1.17% | $15.22M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Millennium management | 958.28K | 0.02% | 915.42K |
Jefferies financial group | 2.04M | 0.75% | 860.00K |
Adar1 capital management | 1.60M | 10.49% | 818.28K |
Qube research | 453.15K | 0.02% | 391.00K |
Price t rowe associates inc /md/ | 1.21M | 0.01% | 390.25K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Morgan stanley | 345.29K | 0.00% | -1.53M |
State street | 2.08M | 0.00% | -1.19M |
Fairmount funds management | - | - | -931.89K |
Bvf inc/il | 3.32M | 3.22% | -436.70K |
Marshall wace, llp | 572.18K | 0.03% | -404.72K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Eagle asset management | 357.63K | 0.07% | 357.63K | $12.59M |
Segall bryant & hamill | 118.56K | 0.07% | 118.56K | $4.11M |
Balyasny asset management | 57.50K | 0.00% | 57.50K | $1.99M |
Mirae asset global etfs | 32.12K | 0.00% | 32.12K | $1.11M |
Corebridge financial | 31.44K | 0.01% | 31.44K | $1.09M |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -11.00 |
Financial gravity asset management | -18.00 |
Innealta capital | -42.00 |
Truvestments capital | -131.00 |
Hillsdale investment management | -170.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 246 | 27.46% | 61,406,077 | 4.02% | 99 | 1.07% | 154 | 69.23% | 65 | -7.14% |
Jun 30, 2024 | 193 | 2.66% | 59,030,802 | -1.50% | 96 | 0.99% | 91 | -17.27% | 70 | 27.27% |
Mar 31, 2024 | 188 | 18.24% | 59,929,938 | 4.29% | 98 | 1.09% | 110 | 54.93% | 55 | -9.84% |
Dec 31, 2023 | 159 | 8.90% | 57,464,862 | 1.33% | 95 | 1.04% | 71 | -12.35% | 61 | 52.50% |
Sep 30, 2023 | 146 | -19.78% | 56,712,373 | -0.03% | 95 | 0.96% | 81 | -22.12% | 40 | -16.67% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
iShares Core S&P Small-Cap ETF | 3.76M | 6.30% | 3.48K |
Vanguard Total Stock Mkt Idx Inv | 1.86M | 3.13% | -10.33K |
Pacer US Small Cap Cash Cows 100 ETF | 1.71M | 2.90% | -439.00 |
iShares Russell 2000 ETF | 1.50M | 2.52% | -3.37K |
SPDR® S&P Biotech ETF | 991.20K | 1.68% | 10.96K |
T. Rowe Price Health Sciences | 990.99K | 1.68% | 24.27K |
Vanguard Institutional Extnd Mkt Idx Tr | 875.57K | 1.49% | -20.85K |
UBS: US Equity Small Cap Growth | 744.87K | 1.26% | - |
Fidelity Small Cap Index | 598.86K | 1.02% | -16.25K |
SPDR® Portfolio S&P 600™ Sm Cap ETF | 519.65K | 0.88% | 3.92K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 15, 2024 | MOLINA ARTURO MD | Chief Medical Officer | Sell | $78.11K |
Sep 11, 2024 | Ali Asif | Chief Financial Officer | Sell | $98.23K |
Sep 11, 2024 | Ali Asif | Chief Financial Officer | Sell | $533.64K |
Sep 10, 2024 | Waddill William D. | - | Sell | $360.00K |
Jul 24, 2024 | Waddill William D. | - | Sell | $320.00K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q3 | - | 4 |
2024 Q2 | - | 4 |
2024 Q1 | - | 7 |
2023 Q4 | - | 2 |
2023 Q2 | - | - |
PTGX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools